Metamizole Sodium

Overview of Metamizole Sodium

Metamizole sodium, also known as dipyrone, is a non-opioid analgesic used primarily for its pain-relieving (analgesic) and fever-reducing (antipyretic) effects. It has been widely utilized in various countries for the treatment of moderate to severe pain and high fever. Despite its efficacy, the use of metamizole sodium has diminished in some regions due to safety concerns, particularly regarding the risk of agranulocytosis.

Brand Origin and Manufacturing

The drug was first developed in Germany in the 1920s and has been marketed under various brand names. The global distribution of metamizole sodium is substantial, with production facilities located in several countries, ensuring wide availability in the pharmaceutical market. Brands producing metamizole sodium are often subsidiaries of larger pharmaceutical companies, which manage quality and distribution across multiple regions.

Ownership Information

Currently, the pharmaceutical formulations of metamizole sodium are owned by various companies around the world. However, the compound is not tied to a single entity, as it has been genericized in many places, allowing for numerous pharmaceutical manufacturers to produce and distribute the medication efficiently. This extensive network has contributed to its presence in healthcare systems globally, especially where it is still considered a necessary analgesic option.